NIH-funded research R01 grant

Investigating brain growth mechanisms in autism using organoid models

Official title: IBIS-iPSC: Organoid modeling of cortical surface area hyperexpansion in autism spectrum disorder

Funded at Univ of North Carolina Chapel Hill · NIH-11067821 · Data updated 2026-11-12

This study is looking at how brain growth works in babies at high risk for autism, using tiny brain models made from their cells to see if they match what happens in their real brains, so we can better understand autism.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startApril 1, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$606,258
NIH project number5R01MH130441-03
Project IDNIH-11067821 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are infants at high familial risk for autism, particularly those who have an older sibling diagnosed with ASD.

Less likely to help

Patients who do not have a familial risk for autism or those who are not infants may not benefit from this research.

What this research studies

This research focuses on understanding the cellular and molecular mechanisms that lead to brain enlargement in individuals with autism spectrum disorder (ASD). By utilizing induced pluripotent stem cell (iPSC)-derived organoids from a well-characterized group of infants at high risk for ASD, the study aims to relate in vitro brain growth patterns to the actual brain development observed in these individuals. Participants in the Infant Brain Imaging Study (IBIS) provide a rich dataset, including neuroimaging and behavioral assessments, which will be used to validate the organoid models. This approach allows researchers to explore how organoid phenotypes can mimic the brain growth trajectories of the children from whom they were derived.

Why it matters

Potential benefit: If successful, this research could lead to a better understanding of the biological mechanisms behind autism, potentially informing future treatments and interventions.

How similar studies have gone: While this approach is innovative, similar studies using organoid models have shown promise in understanding other neurodevelopmental disorders, indicating potential for success in this area as well.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Stein, Jason Louis — Univ of North Carolina Chapel Hill
  • Study coordinator: Stein, Jason Louis

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.